Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919630 | Radiotherapy and Oncology | 2011 | 6 Pages |
Abstract
All modalities evaluated provide adequate coverage of the intact breast. HT, topotherapy, and inv-IMRT can reduce high doses to the target and normal tissues, although HT results in increased low doses to large volume of normal tissue. For-IMRT improves target homogeneity compared with 3DCRT, but to a lesser degree than the inverse-planned modalities.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Leah K. Schubert, Vinai Gondi, Evan Sengbusch, David C. Westerly, Emilie T. Soisson, Bhudatt R. Paliwal, Thomas Rockwell Mackie, Minesh P. Mehta, Rakesh R. Patel, Wolfgang A. Tomé, George M. Cannon,